Reproducibility of aortic valve calcification scoring with computed tomography - An interplatform analysis.


Journal

Journal of cardiovascular computed tomography
ISSN: 1876-861X
Titre abrégé: J Cardiovasc Comput Tomogr
Pays: United States
ID NLM: 101308347

Informations de publication

Date de publication:
Historique:
received: 12 06 2018
revised: 20 10 2018
accepted: 14 01 2019
pubmed: 23 1 2019
medline: 14 6 2019
entrez: 23 1 2019
Statut: ppublish

Résumé

To investigate whether aortic valve calcification (AVC) scoring performed with different workstation platforms generates comparable and thus software-independent results. In this IRB-approved retrospective study, we included 100 consecutive patients with symptomatic aortic stenosis undergoing CT prior to transcatheter aortic valve implantation. Two independent observers performed AVC scoring on non-enhanced images with commercially available software platforms of four vendors (GE, Philips, Siemens, 3mensio). Gender-specific Agatston score cut-off values were applied according to current recommendations to assign patients to different likelihood categories of aortic stenosis (unlikely to very likely). Comparative analysis of Agatston scores between the four platforms were performed by using Kruskal-Wallis analysis, Spearman rank correlation, linear regression analysis, and Bland-Altman analysis. Differences in category assignment were compared using Fisher's exact test and Cohen's kappa. For both observers, each workstation platform produced slightly different numeric AVC Agatston scores, however, without statistical significance (p = 0.96 and p = 0.98). Excellent correlation was found between platforms, with r = 0.991-0.996 (Spearman) and r While absolute values differ slightly, common commercially available software platforms produce comparable results for AVC scoring, which indicates software-independence of the method.

Sections du résumé

BACKGROUND BACKGROUND
To investigate whether aortic valve calcification (AVC) scoring performed with different workstation platforms generates comparable and thus software-independent results.
METHODS METHODS
In this IRB-approved retrospective study, we included 100 consecutive patients with symptomatic aortic stenosis undergoing CT prior to transcatheter aortic valve implantation. Two independent observers performed AVC scoring on non-enhanced images with commercially available software platforms of four vendors (GE, Philips, Siemens, 3mensio). Gender-specific Agatston score cut-off values were applied according to current recommendations to assign patients to different likelihood categories of aortic stenosis (unlikely to very likely). Comparative analysis of Agatston scores between the four platforms were performed by using Kruskal-Wallis analysis, Spearman rank correlation, linear regression analysis, and Bland-Altman analysis. Differences in category assignment were compared using Fisher's exact test and Cohen's kappa.
RESULTS RESULTS
For both observers, each workstation platform produced slightly different numeric AVC Agatston scores, however, without statistical significance (p = 0.96 and p = 0.98). Excellent correlation was found between platforms, with r = 0.991-0.996 (Spearman) and r
CONCLUSION CONCLUSIONS
While absolute values differ slightly, common commercially available software platforms produce comparable results for AVC scoring, which indicates software-independence of the method.

Identifiants

pubmed: 30665879
pii: S1934-5925(18)30183-7
doi: 10.1016/j.jcct.2019.01.016
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-98

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

M Eberhard (M)

Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland.

R Hinzpeter (R)

Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland.

M Polacin (M)

Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland.

F Morsbach (F)

Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland.

F Maisano (F)

University Heart Center Zurich, University of Zurich, Switzerland.

F Nietlispach (F)

University Heart Center Zurich, University of Zurich, Switzerland.

T D L Nguyen-Kim (TDL)

Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland.

F C Tanner (FC)

University Heart Center Zurich, University of Zurich, Switzerland.

H Alkadhi (H)

Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland. Electronic address: hatem.alkadhi@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH